AI, Welfare & Long-term Care News ・ 🧠 Dementia care

Lion Bio's Robin Guo: Nasal Peptides and AI Could Crack Alzheimer's Within a Decade — If Delivery Doesn't Block It First

BigGo Finance · 11/07 17:08 UTC

Robin Guo spent five years as a consumer AI investor at Andreessen Horowitz before co-founding the peptide startup Lion Bio. He argues that the next step in Alzheimer's research involves nasal peptides and AI.

Read the original (BigGo Finance)

See it in the digest → ・ See this issue →